Breaking News, Promotions & Moves

Catalent Provides Business Update, Names Ricky Hopson Interim CFO

Productivity issues and higher-than-expected costs will adversely impact the company’s financial results for the third quarter.

Catalent Inc. reported a business update and appointed Ricky Hopson interim chief financial officer. Hopson, who had been serving as the company’s president, division head for clinical development & supply, assumed the role of interim chief financial officer on April 14. He replaces Thomas Castellano who left the company. The company is engaging a leading, global executive search firm to evaluate candidates for a permanent CFO. “Ricky is an experienced financial executive who deeply under...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters